| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.03. | LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 30.03. | LEE'S PHARMACEUTICAL Last Year's Net Profit Down 1.2% to HKD91.94 Million; Final Dividend of HKD0.023 | 2 | AASTOCKS | ||
| 30.03. | Lee's Pharmaceutical Holdings Ltd. Reports Retreat In Full Year Bottom Line | 1 | RTTNews | ||
| 30.03. | LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 27.03. | LEE'S PHARM Last Year's Loss Expanded to USD4.71 Million | 1 | AASTOCKS | ||
| 25.03. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - APPROVAL OF INTRAROSA BY NMPA | - | HKEx | ||
| 17.03. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 5 | HKEx | ||
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx | ||
| 22.12.25 | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 5 | HKEx | ||
| 18.12.25 | LEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA | 1 | HKEx | ||
| 11.12.25 | Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 579 | PR Newswire | Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline... ► Artikel lesen | |
| 11.12.25 | Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 375 | PR Newswire | Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential
Synergistic and complementary to Lee's Pharm's existing products... ► Artikel lesen | |
| 08.12.25 | LEE'S PHARM (00950): DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 1 | HKEx | ||
| 15.10.25 | LEE'S PHARM (00950): GRANT OF SHARE OPTIONS | 2 | HKEx | ||
| 12.09.25 | Dividendenbekanntmachungen (12.09.2025) | 12.873 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,887 USD 0,7558 EUR ACADIAN ASSET MANAGEMENT INC US10948W1036 0,01 USD 0,0085 EUR ALBEMARLE... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 118,00 | -0,46 % | Gilead übernimmt Tubulis und erweitert damit seine Onkologie-Pipeline | München - Gilead Sciences, Inc. (Nasdaq: GILD) gab bekannt, dass es eine endgültige Vereinbarung zur Übernahme der Tubulis GmbH geschlossen hat, eines privaten deutschen Biotechnologieunternehmens im... ► Artikel lesen | |
| ZOETIS | 100,05 | -0,45 % | Zoetis Inc. to Acquire Animal Genomics Business from Neogen, Accelerating Precision Animal Health Innovation | Acquisition strengthens Zoetis' leadership in Precision Animal Health by integrating Neogen's global genomics capabilities, expanding predictive insights and individualized care worldwide
PARSIPPANY... ► Artikel lesen | |
| SINOPHARM | 2,250 | -0,35 % | SINOPHARM (01099): NOTICE OF BOARD MEETING | ||
| CSPC PHARMA | 0,998 | -0,63 % | CSPC PHARMA (01093): UPDATE ANNOUNCEMENT - CONNECTED TRANSACTION IN RELATION TO THE DISPOSAL OF 30.0704% EQUITY INTEREST IN THE TARGET COMPANY | ||
| WUXI BIOLOGICS | 4,005 | +1,14 % | WuXi Biologics Reports Record 2025 Annual Results | Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY
IFRS gross profit margin expanded to 46.0% (+500 bps... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,150 | -0,05 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| GEDEON RICHTER | 33,840 | 0,00 % | Richter Board Proposes HUF 656-per-Share Dividend | ||
| DR REDDYS | 11,200 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,035 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue | FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance... ► Artikel lesen | |
| ASPEN PHARMACARE | 6,700 | +0,75 % | ASPEN PHARMACARE HOLDINGS LIMITED - Distribution of circular to shareholders and notice of general meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,370 | +5,38 % | CLSA Raises Shanghai Pharmaceuticals TP to HKD15.2, Rating Outperform | ||
| LUYE PHARMA | 0,304 | 0,00 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT FIRST SUBJECT ENROLLED IN THE PHASE II CLINICAL TRIAL IN CHINA OF THE GROUP'S INNOVATIVE DRUG LY03020 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,152 | -1,94 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - LICENSING AND SUPPLY AGREEMENT REACHED BETWEEN XUANZHU BIOPHARM AND BOSTON ONCOLOGY FOR BIREOCICLIB AND ... | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,670 | -0,74 % | HSI Closes at 24,788, Up 37 pts; HSTI Closes at 4,649, Down 40 pts; HANSOH PHARMA Up over 7%; ICBC, BANK OF CHINA, GOFINTECH QUANT, GUANGDONG INV, CHINARES PHARMA Hit New Highs; Market Turnover Rises | ||
| HANSOH PHARMACEUTICAL | 4,147 | -0,55 % | BOCOM International Lowers Hansoh Pharmaceutical TP to HKD44.5 as Last Year's Results Exceeded Expectations |